title: Relationship between chronic kidney disease prevalence and end-stage renal disease risk.
abstract: OBJECTIVE
  Incidence of end-stage renal disease has increased dramatically during the last 30 years and screening for early stages of chronic kidney disease is often suggested as a preventive measure. The relationship between chronic kidney disease and end-stage renal disease is complex, however, and recent studies have given some insights into this relationship. The review will summarize these studies and briefly discuss the clinical implications.
  
  
  RESULTS
  While the prevalence of chronic kidney disease is high in most Western countries, the incidence of end-stage renal disease differs substantially. The general increase in the incidence of end-stage renal disease seen in recent years may be partially explained by a lower cardiovascular mortality, allowing more patients with chronic kidney disease to develop end-stage renal disease, and widening of entrance criteria for renal replacement therapy. Data do not, however, support these factors as explanatory for the existing international differences. These differences are better explained by different prevalences of diabetes and obesity as well as by differences in rate of progression from early chronic kidney disease stages to end-stage renal disease. Rate of progression seems to be affected by race, socioeconomic status and predialytic care.
  
  
  CONCLUSIONS
  Several mechanisms influence the relationship between chronic kidney disease and risk of end-stage renal disease. Decreased cardiovascular mortality and improved treatment availability may explain parts of the increase in the incidence of end-stage renal disease, and there are also large international differences in rates of progression from chronic kidney disease to end-stage renal disease that may be amendable by public health and predialytic care interventions.
authors.affiliation: Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway. stein.hallan@ntnu.no
authors.forename: Stein Ivar
authors.initials: SI
authors.lastname: Hallan
authors.forename: Bjørn Egil
authors.initials: BE
authors.lastname: Vikse
mesh_terms: D002318:Cardiovascular Diseases / Q000150:complications / Q000401:mortality; D002908:Chronic Disease; D048909:Diabetes Complications / Q000209:etiology; D018450:Disease Progression; D006297:Health Services Accessibility; D054625:Healthcare Disparities; D006801:Humans; D006973:Hypertension / Q000150:complications; D015994:Incidence; D007674:Kidney Diseases / Q000150:complications* / Q000208:ethnology / Q000401:mortality / Q000628:therapy; D007676:Kidney Failure, Chronic / Q000208:ethnology / Q000209:etiology* / Q000401:mortality / Q000517:prevention & control; D009765:Obesity / Q000150:complications; D015995:Prevalence; D012307:Risk Factors; D012959:Socioeconomic Factors